Abstract:Background: Kidney transplantation is the optimal treatment option for most patients with end-stage kidney disease given the significantly lower morbidity and mortality rates compared to remaining on dialysis. Rejection and graft failure remain common in transplant recipients with limited improvement in long-term transplant outcomes despite therapeutic advances. There is an unmet need in the development of non-invasive biomarkers that specifically monitor graft function and predict transplant pathologies that affect outcomes. Despite the potential of proteomic investigatory approaches, up to now, no candidate biomarkers of sufficient sensitivity or specificity have translated into clinical use. The aim of this review was to collate and summarise protein findings and protein pathways implicated in the literature to date, and potentially flag putative biomarkers worth validating in independent patient cohorts. Methods: This review followed the Joanna Briggs' Institute Methodology for a scoping review. MedlineALL, Embase, Web of Science Core Collection, Scopus and Google Scholar databases were searched from inception until December 2022. Abstract and full text review were undertaken independently by two reviewers. Data was collated using a pre-designed data extraction tool. Results: One hundred one articles met the inclusion criteria. The majority were single-centre retrospective studies of small sample size. Mass spectrometry was the most used technique to evaluate differentially expressed proteins between diagnostic groups and studies identified various candidate biomarkers such as immune or structural proteins. Discussion: Putative immune or structural protein candidate biomarkers have been identified using proteomic techniques in multiple sample types including urine, serum and fluid used to perfuse donor kidneys. The most consistent findings implicated proteins associated with tubular dysfunction and immunological regulatory pathways such as leukocyte trafficking. However, clinical translation and adoption of candidate biomarkers is limited, and these will require comprehensive evaluation in larger prospective, multicentre trials.

Quantitative Proteomics for Monitoring Renal Transplant Injury

Diagnosis of T-Cell-Mediated Kidney Rejection by Biopsy-Based Proteomics and Machine Learning

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Biomarkers for Renal Transplantation: Where Are We?

Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis

Feasibility of Diagnosing Renal Allograft Dysfunction by Oligonucleotide Array: Gene Expression Profile Correlates with Histopathology.

Proteomic analysis of differentially expressed proteins in the serum of patients with acute renal allograft rejection using iTRAQ labelling technology

Urine proteomics in kidney transplantation

[Preliminary Exploration in Proteomic-Based Mechanistic Analysis of Patients with Acute Renal Allograft Rejection].

Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection

Highly Repeatable Tissue Proteomics for Kidney Transplant Pathology: Technical and Biological Validation of Protein Analysis using LC-MS/MS

Screening of novel biomarkers for acute kidney transplant rejection using DIA‐MS based proteomics

Predicting Cellular Rejection of Renal Allograft Based on the Serum Proteomic Fingerprint

Urinary metabolomics in monitoring acute tubular injury of renal allografts: a preliminary report.

Kidney Transplant Rejection and Tissue Injury by Gene Profiling of Biopsies and Peripheral Blood Lymphocytes

Prediction of Acute Cellular Renal Allograft Rejection by Urinary Metabolomics Using MALDI-FTMS

Prediction of acute rejection in kidney transplanted patients based on the point-of-care isothermal molecular diagnostics platform

Proteomic analysis investigating kidney transplantation outcomes- a scoping review

Computational pathology model to assess acute and chronic transformations of the tubulointerstitial compartment in renal allograft biopsies

Using established biorepositories for emerging research questions: a feasibility study

Data‐Independent Acquisition‐Based Quantitative Proteomic Analysis Reveals Potential Biomarkers of Kidney Cancer